EUVIMEDEUVIMED entdecken
Open Access

EMBARK in biochemically recurrent prostate cancer: a journey for some but not most

Melissa L Abel, Fatima Karzai iD, Ravi A Madan iD

The Oncologist · 10.04.2026 · 31 (5)

DOI: 10.1093/oncolo/oyag101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 08.04.2026. Verfasst von Melissa L Abel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Biochemically recurrent prostate cancerPSA Doubling TimePatient SelectionProstate cancerbiomarker

Autor:innen und Institutionen

  • Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

ORCID-Profile: Fatima Karzai, Ravi A Madan

Zitieren

APA

Abel, M. L., Karzai, F., & Madan, R. A. (2026). EMBARK in biochemically recurrent prostate cancer: a journey for some but not most. The Oncologist, 31(5). https://doi.org/10.1093/oncolo/oyag101

Vancouver

Abel ML, Karzai F, Madan RA. EMBARK in biochemically recurrent prostate cancer: a journey for some but not most. The Oncologist. 2026;31(5). doi:10.1093/oncolo/oyag101

BibTeX
@article{Abel2026,
  author = {Abel, Melissa L and Karzai, Fatima and Madan, Ravi A},
  title = {EMBARK in biochemically recurrent prostate cancer: a journey for some but not most},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {5},
  doi = {10.1093/oncolo/oyag101}
}
Kostenlos starten →